Oncology Supply Competitors and Similar CompaniesClear all

Oncology Supply's competitors and similar companies include Loxo Oncology, Syndax Pharmaceuticals, PDL BioPharma and Glycotope.

	Oncology Supply Oncology Supply is a pharmaceutical service that delivers chemotherapy and supportive care products to independent oncology practices.	Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.	Syndax Pharmaceuticals Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.	PDL BioPharma PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.	Glycotope Glycotope is a clinical stage biotechnology company.
Founding Date	Founding Date 1978	Founding Date 2013	Founding Date 2005	Founding Date 1986	Founding Date 2001
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech distribution oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Dothan, US HQ	Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US	Locations Waltham, US HQ New York, US Waltham, US	Locations Incline Village, US HQ	Locations Berlin, DE HQ
Employees	Employees 1042% decrease	Employees 65610% decrease	Employees 358% decrease	Employees 10521% increase	Employees 931% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.6 b	Valuation ($) 282.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $172.4m (FY, 2025)	Revenue (est.) $54.8m (FY, 2019)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($148.9m) (FY, 2017)	Net income ($285.4m) (FY, 2025)	Net income ($70.7m) (FY, 2019)	Net income N/A